CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Flexible Sigmoidoscopy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00075062
NCT00075062N/ACompleted
CompareCT.gov

Characteristics of Baseline Mucosal Indices of Injury and Inflammation in Men For Use in Rectal Microbicide Trials

National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Jan 1, 2004·Updated Aug 21, 2008

In Brief

An observational study evaluating Flexible Sigmoidoscopy and Rectal Biopsy for HIV Infections and HIV Seronegativity. Completed, across 1 site.

Detailed Summary

Microbicides are drugs that destroy microbes such as viruses and bacteria. Rectal microbicides may be able to prevent transmission of HIV during anal intercourse. The purpose of this study is to obtain rectal samples from men to learn information that may be valuable in future clinical trials of rectal microbicides.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections, HIV Seronegativity
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 1, 2004
TodayJul 2, 2026
Posted 22.5 years ago

Interventions

Flexible Sigmoidoscopyprocedure

Rectal Biopsyprocedure